MedPath

Iodine Status and Characteristics of Papillary Thyroid Cancer

Not yet recruiting
Conditions
Papillary Thyroid Carcinoma
Interventions
Dietary Supplement: Iodine excess
Dietary Supplement: Iodine suitable
Registration Number
NCT06626581
Lead Sponsor
Shandong Provincial Hospital
Brief Summary

The effect of iodine on papillary thyroid cancer has been controversial for many years. The investigators designed a cross-sectional study and aimed to explore the relationship between the serum and urine iodine levels and the clinical and molecular characteristics of papillary thyroid cancer.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
600
Inclusion Criteria
  • Age range: 18~65 years old, gender not limited;
  • Living in the residential area for at least 5 years;
  • Patients diagnosed clinically with thyroid cancer and scheduled for thyroid surgery, with pathological diagnosis of papillary thyroid cancer;
  • Complete clinical data: including general information, relevant laboratory tests, pathological reports, surgical reports, ultrasound reports, etc.
Exclusion Criteria
  • Pathological diagnosis of other types of thyroid cancer;
  • Diagnosed with other types of cancer;
  • There are serious comorbidities of the heart, liver, and kidneys;

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Excessive iodine groupIodine excessResidents with papillary thyroid cancer who have lived in excessive iodine areas for a long time (5 years or more). According to the report of Shandong linstitute of Endemic Disease Prevention and Control, three sub centers were selected in excessive iodine group(Jining/Liaocheng/Heze).
Suitable iodine groupIodine suitableResidents with papillary thyroid cancer who have lived in suitable iodine areas for a long time (5 years or more). According to the report of Shandong linstitute of Endemic Disease Prevention and Control, three sub centers were selected in suitable iodine group(Jinan/Shenyang/Haerbin).
Primary Outcome Measures
NameTimeMethod
Serum and urine iodine levels1 year from enrollment
TNM staging of papillary thyroid cancer3 month from enrollment
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath